Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 785382, 6 pages
http://dx.doi.org/10.1155/2014/785382
Review Article

Plant Virus Expression Vector Development: New Perspectives

Cornell University, Ithaca, NY 14850, USA

Received 7 December 2013; Accepted 11 February 2014; Published 13 March 2014

Academic Editor: Chenming (Mike) Zhang

Copyright © 2014 Kathleen Hefferon. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. T. Hamorsky, J. C. Kouokam, L. J. Bennett et al., “Rapid and scalable plant-based production of a cholera toxin B subunit variant to aid in mass vaccination against cholera outbreaks,” Public Library of Sciences Neglected Tropical Diseases, vol. 7, no. 3, article e2046, 2013. View at Google Scholar
  2. A. A. McCormick, S. Reddy, S. J. Reinl et al., “Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 29, pp. 10131–10136, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Leuzinger, M. Dent, J. Hurtado et al., “Efficient agroinfiltration of plants for high-level transient expression of recombinant proteins,” Journal of Visual Experimentation, no. 77, 2013. View at Publisher · View at Google Scholar
  4. Y. Gleba, S. Marillonnet, and V. Klimyuk, “Engineering viral expression vectors for plants: the “full virus” and the “deconstructed virus” strategies,” Current Opinion in Plant Biology, vol. 7, no. 2, pp. 182–188, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Klimyuk, G. Pogue, S. Herz, J. Butler, and H. Haydon, “Production of recombinant antigens and antibodies in Nicotiana benthamiana using “Magnifection” technology: GMP-compliant facilities for small- and large-scale manufacturing,” Current Topics in Microbiology and Immunology, vol. 375, pp. 127–154, 2014. View at Google Scholar
  6. S. Kagale, S. Uzuhashi, M. Wigness et al., “TMV-Gate vectors: gateway compatible tobacco mosaic virus based expression vectors for functional analysis of proteins,” Science Reports, vol. 2, article 874, 2012. View at Google Scholar
  7. J. A. Lindbo, “High-efficiency protein expression in plants from agroinfection-compatible Tobacco mosaic virus expression vectors,” BMC Biotechnology, vol. 7, article 52, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. J. A. Lindbo, “TRBO: a high-efficiency tobacco mosaic virus RNA-based overexpression vector,” Plant Physiology, vol. 145, no. 4, pp. 1232–1240, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. K. T. Hamorsky, T. W. Grooms-Williams, A. S. Husk, L. J. Bennett, K. E. Palmer, and N. Nobuyuki Matoba, “Efficient single tobamoviral vector-based bioproduction of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 in Nicotiana benthamiana plants and utility of VRC01 in combination microbicides,” Antimicrobial Agents and Chemotherapy, vol. 57, no. 5, pp. 2076–2086, 2013. View at Publisher · View at Google Scholar
  10. N. V. Petukhova, T. V. Gasanova, L. A. Stepanova et al., “Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by Tobacco mosaic virus-based vectors,” Current Pharmaceutical Design, vol. 19, no. 31, pp. 5587–5600, 2013. View at Google Scholar
  11. V. Yusibov, S. J. Streatfield, N. Kushnir, G. Roy, and A. Padmanaban, “Hybrid viral vectors for vaccine and antibody production in plants,” Current Pharmaceutical Design, vol. 19, no. 31, pp. 5574–5586, 2013. View at Google Scholar
  12. Y. Shoji, R. M. Jones, V. Mett et al., “A plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challenge,” Human Vaccine Immunotherapy, vol. 9, no. 3, 2013. View at Google Scholar
  13. J. F. Cummings, M. L. Guerrero, J. E. Moon et al., “Safety and immunogenicity of a plant-produced recombinantmonomer hemagglutinin-based influenza vaccine derived frominfluenza A (H1N1)pdm09 virus: a Phase 1 dose-escalation study in healthy adults,” Vaccine Journal, 2013. View at Publisher · View at Google Scholar
  14. V. Neuhaus, K. Schwarz, A. Klee et al., “Functional testing of an inhalable nanoparticle based influenza vaccine using a human precision cut lung slice technique,” PLoS ONE, vol. 8, no. 8, Article ID e71728, 2013. View at Publisher · View at Google Scholar
  15. L.-P. Vezina, M. A. D’Aoust, N. Landry et al., “Plants as an innovative and accelerated vaccine-manufacturing solution,” BioPharmaceutical International Supplementary, vol. 24, no. 5, pp. s27–s30, 2011. View at Google Scholar
  16. C. Li, Y. Jiang, W. Guo, and Z. Liu, “Production of a chimeric allergen derived from the major allergen group 1 of house dust mite species in Nicotiana benthamiana,” Human Immunology, vol. 74, no. 5, pp. 531–537, 2013. View at Google Scholar
  17. H. Nausch, H. Mikschofsky, R. Koslowski, U. Meyer, I. Broer, and J. Huckauf, “Expression and subcellular targeting of human complement factor C5a in Nicotiana species,” PLoS ONE, vol. 7, no. 12, 2012. View at Google Scholar
  18. K. Azhakanandam, S. M. Weissinger, J. S. Nicholson, R. Qu, and A. K. Weissinger, “Amplicon-plus targeting technology (APTT) for rapid production of a highly unstable vaccine protein in tobacco plants,” Plant Molecular Biology, vol. 63, no. 3, pp. 393–404, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Cerovska, H. Hoffmeisterova, T. Moravec et al., “Transient expression of Human papillomavirus type 16 L2 epitope fused to N- and C-terminus of coat protein of Potato virus X in plants,” Journal of Biosciences, vol. 37, no. 1, pp. 125–133, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Minato, K. Komatsu, Y. Okano et al., “Efficient foreign gene expression in planta using a plantago asiatica mosaic virus-based vector achieved by the strong RNA-silencing suppressor activity of TGBp1,” Archives of Virology. In press.
  21. M. S. Hwang, B. E. Lindenmuth, K. A. McDonald, W. Bryce, and B. Falk, “Bipartite and tripartite Cucumber mosaic virus-based vectors for producing the Acidothermus cellulolyticus endo-1,4-β-glucanase and other proteins in non-transgenic plants,” BMC Biotechnology, vol. 12, article 66, 2012. View at Google Scholar
  22. A. Gellért, K. Salánki, K. Tombácz, T. Tuboly, and E. Balázs, “A cucumber mosaic virus based expression system for the production of porcine circovirus specific vaccines,” PLoS ONE, vol. 7, no. 12, Article ID e52688, 2012. View at Publisher · View at Google Scholar
  23. H. Peyret and G. P. Lomonossoff, “The pEAQ vector series: the easy and quick way to produce recombinant proteins in plants,” Plant Molecular Biology, no. 1-2, pp. 51–58, 2013. View at Google Scholar
  24. M.-A. D'Aoust, P.-O. Lavoie, M. M.-J. Couture et al., “Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice,” Plant Biotechnology Journal, vol. 6, no. 9, pp. 930–940, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Sainsbury, M. Sack, J. Stadlmann, H. Quendler, R. Fischer, and G. P. Lomonossoff, “Rapid transient production in plants by replicating and non-replicating vectors yields high quality functional anti-HIV antibody,” PLoS ONE, vol. 5, no. 11, Article ID e13976, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. E. C. Thuenemann, A. E. Meyers, J. Verwey, E. P. Rybicki, and G. P. Lomonossoff, “A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus-like particles,” Plant Biotechnology Journal, vol. 11, no. 7, pp. 839–846, 2013. View at Google Scholar
  27. Q. Chen, J. He, W. Phoolcharoen, and H. S. Mason, “Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants,” Human Vaccines, vol. 7, no. 3, pp. 331–338, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Y. Chung, H. H. Lee, K. I. Kim et al., “Expression of a recombinant chimeric protein of hepatitis A virus VP1-Fc using a replicating vector based on Beet curly top virus in tobacco leaves and its immunogenicity in mice,” Plant Cell Reports, vol. 30, no. 8, pp. 1513–1521, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. C.-F. Cho, S. Shukla, E. J. Simpson et al., “Molecular targeted viral nanoparticles as tools for imaging cancer,” in Virus Hybrids as Nanomaterials: Methods and Protocols, Methods in Molecular Biology, vol. 1108, Springer Science, Business Media, New York, NY, USA, 2014. View at Publisher · View at Google Scholar
  30. N. F. Steinmetz, C.-F. Cho, A. Ablack, J. D. Lewis, and M. Manchester, “Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells,” Nanomedicine, vol. 6, no. 2, pp. 351–364, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. N. F. Steinmetz, A. L. Ablack, J. L. Hickey et al., “Intravital imaging of human prostate cancer using viral nanoparticles targeted to gastrin-releasing peptide receptors,” Small, vol. 7, no. 12, pp. 1664–1672, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. O. Azizgolshani, R. F. Garmann, R. Cadena-Nava, C. M. Knobler, and W. M. Gelbart, “Reconstituted plant viral capsids can release genes to mammalian cells,” Virology, vol. 441, no. 1, pp. 12–17, 2013. View at Google Scholar
  33. P. Lacasse, J. Denis, R. Lapointe, D. Leclerc, and A. Lamarre, “Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation,” Journal of Virology, vol. 82, no. 2, pp. 785–794, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Savard, A. Guérin, K. Drouin et al., “Improvement of the trivalent inactivated flu vaccine using papmv nanoparticles,” PLoS ONE, vol. 6, no. 6, Article ID e21522, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. A. A. McCormick, T. A. Corbo, S. Wykoff-Clary et al., “TMV-peptide fusion vaccines induce cell-mediated immune responses and tumor protection in two murine models,” Vaccine, vol. 24, no. 40-41, pp. 6414–6423, 2006. View at Publisher · View at Google Scholar · View at Scopus